Literature DB >> 14474744

Attenuated measles vaccine in children with acute leukemia.

A MITUS, A HOLLOWAY, A E EVANS, J F ENDERS.   

Abstract

Entities:  

Keywords:  LEUKEMIA/complications; MEASLES/immunology; VACCINATION/complications

Mesh：

Substances：

Year:  1962        PMID： 14474744     DOI： 10.1001/archpedi.1962.02080020425051

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN： 0002-922X


× No keyword cloud information.
  29 in total

1.  Independence of measles-specific humoral and cellular immune responses to vaccination.

Authors:  Robert M Jacobson; Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Hum Immunol       Date:  2012-03-03       Impact factor: 2.850

2.  MEASLES IN CHILDREN WITH MALIGNANCY PROBLEMS AND PREVENTION.

Authors:  A MITUS; J F ENDERS; G EDSALL; A HOLLOWAY
Journal:  Arch Gesamte Virusforsch       Date:  1965

3.  THE PATHOGENESIS OF MEASLES VIRUS INFECTION.

Authors:  C H KEMPE; V A FULGINITI
Journal:  Arch Gesamte Virusforsch       Date:  1965

4.  Measles vaccination: Weighing the benefits and risks of a live viral vaccine for HIV-infected children.

Authors: 
Journal:  Can J Infect Dis       Date:  1996-07

5.  Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination.

Authors:  N Dhiman; I G Ovsyannikova; J E Ryan; R M Jacobson; R A Vierkant; V S Pankratz; S J Jacobsen; G A Poland
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

6.  Octamerization enables soluble CD46 receptor to neutralize measles virus in vitro and in vivo.

Authors:  D Christiansen; P Devaux; B Réveil; A Evlashev; B Horvat; J Lamy; C Rabourdin-Combe; J H Cohen; D Gerlier
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice.

Authors:  B Mrkic; B Odermatt; M A Klein; M A Billeter; J Pavlovic; R Cattaneo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 8.  Preventing infective complications in inflammatory bowel disease.

Authors:  Justine Mill; Ian C Lawrance
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 9.  Virus infections in patients with malignant disease.

Authors:  R B Heath
Journal:  Postgrad Med J       Date:  1969-01       Impact factor: 2.401

10.  Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.

Authors:  Inna G Ovsyannikova; Neelam Dhiman; Robert M Jacobson; Robert A Vierkant; Gregory A Poland
Journal:  Clin Diagn Lab Immunol       Date:  2003-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.